Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Carmen L Lewis, MD, MPH
University of North Carolina, Chapel Hill
Principal Investigator - Ming Tai-Seale, Ph.D, MPH
Palo Alto Medical Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Palo Alto Medical Foundation Research Institute
Palo Alto, California, United States
- University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 31 Jan 2013
- Completion
- 31 Jan 2013
- Last update posted
- 23 Dec 2014
- Registered enrollment
- 218
- Registry id
- NCT01244568
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.